Table S3. Comparison of the C-index for OS in the training set.
C-index | PS | gastrectomy | Histological type | HER2 | Number of metastases | Peritoneal metastasis | Bone metastasis | ALP | LDH |
---|---|---|---|---|---|---|---|---|---|
0.670 | ○ | ○ | ○ | ○ | ○ | ||||
0.664 | ○ | ○ | ○ | ○ | ○ | ||||
0.664 | ○ | ○ | ○ | ○ | ○ | ||||
0.684 | ○ | ○ | ○ | ○ | ○ | ||||
0.678 | ○ | ○ | ○ | ○ | ○ | ||||
0.670 | ○ | ○ | ○ | ○ | ○ | ||||
0.670 | ○ | ○ | ○ | ○ | ○ | ||||
0.683 | ○ | ○ | ○ | ○ | ○ | ||||
0.682 | ○ | ○ | ○ | ○ | ○ | ||||
0.661 | ○ | ○ | ○ | ○ | ○ | ||||
0.681 | ○ | ○ | ○ | ○ | ○ | ||||
0.677 | ○ | ○ | ○ | ○ | ○ | ||||
0.684 | ○ | ○ | ○ | ○ | ○ | ||||
0.678 | ○ | ○ | ○ | ○ | ○ | ||||
0.688 | ○ | ○ | ○ | ○ | ○ | ||||
0.668 | ○ | ○ | ○ | ○ | ○ | ||||
0.666 | ○ | ○ | ○ | ○ | ○ | ||||
0.682 | ○ | ○ | ○ | ○ | ○ | ||||
0.679 | ○ | ○ | ○ | ○ | ○ | ||||
0.651 | ○ | ○ | ○ | ○ | ○ | ||||
0.675 | ○ | ○ | ○ | ○ | ○ | ||||
0.671 | ○ | ○ | ○ | ○ | ○ | ||||
0.679 | ○ | ○ | ○ | ○ | ○ | ||||
0.673 | ○ | ○ | ○ | ○ | ○ | ||||
0.683 | ○ | ○ | ○ | ○ | ○ | ||||
0.666 | ○ | ○ | ○ | ○ | ○ | ||||
0.680 | ○ | ○ | ○ | ○ | ○ | ||||
0.677 | ○ | ○ | ○ | ○ | ○ | ||||
0.680 | ○ | ○ | ○ | ○ | ○ | ||||
0.677 | ○ | ○ | ○ | ○ | ○ | ||||
0.687 | ○ | ○ | ○ | ○ | ○ | ||||
0.673 | ○ | ○ | ○ | ○ | ○ | ||||
0.670 | ○ | ○ | ○ | ○ | ○ | ||||
0.682 | ○ | ○ | ○ | ○ | ○ | ||||
0.680 | ○ | ○ | ○ | ○ | ○ |
The circle means that the variable is included into the model; the data in italic form indicate that the top five models. ALP, alkaline phosphatase; HER2, human epidermal growth factor receptor type 2; LDH, lactate dehydrogenase; PS, performance status.